The impact of cost containment reforms to the Pharmaceutical Benefits Scheme (PBS) on prescribing volumes and expenditure in Australia: 1992-2011
|dc.contributor.author||Lee, Kah Seng|
|dc.contributor.supervisor||Assoc. Prof. Rachael Moorin|
|dc.contributor.supervisor||Dr Delia Hendrie|
|dc.contributor.supervisor||Prof. Bruce Sunderland|
Objectives: To investigate the impact of cost containment measures on PBS prescribing volumes and expenditure. Methods: Segmented linear regression models were used to analyse the time series data from Medicare Australia’s PBS Statistics. Seven measures and four new listing dates of statins were investigated. Results: Many of the cost containment measures were effective in containing costs. Conclusions: The safety net 20 days rule was estimated to be the most effective in reducing drugs utilisation and expenditure.
|dc.title||The impact of cost containment reforms to the Pharmaceutical Benefits Scheme (PBS) on prescribing volumes and expenditure in Australia: 1992-2011|
|curtin.department||School of Pharmacy|